+1 (905) 564-5665

info@septapharma.com

7035 Maxwell Rd

Mississauga, ON. L5S 1R5 Canada

  • Home
  • About Us
    • Who We Are
    • Leadership
    • Culture
    • Social and Environmental Responsibility
    • Governance, Risk Management & Compliance
  • Business
    • Pharmaceuticals
    • Clinical Research
    • Nutraceuticals
    • TurnKey Solutions
  • Careers
  • Contact Us

Resources

  1. Homepage
  2. Resources
  3. Resources
Resources

Resources

    Aminophylline 25 mg/ mL (UK)
  • Product Monograph
  • Risk Communication EN
  • Risk Communication FR
  • Carbamazepine Extended-Release Tablets, USP 200 mg and 400 mg (USA)
  • Product Monograph
  • Risk Communication EN
  • Risk Communication FR
  • Gleostine (Lomustine) Capsules, 10 mg and 40 mg (USA)
  • Product Monograph
  • Risk Communication EN
  • Risk Communication FR
  • Prev

    Septa Pharma Inc. Receives Health Canada Approval to Import Aminophylline Injection Amidst Critical Canadian Shortage

    Next

    Septa Pharma Inc. Receives Health Canada Approval to Import Carbamazepine Extended Release Tablets Amidst Canadian Shortage

    Septa is proudly a Canadian owned and operated healthcare company.

    Our mission is to provide quality pharmaceuticals and healthcare products and services to advance and nourish the quality of life both, domestically and globally.

    Head Quarters

    CANADA

    7035 Maxwell Rd, Mississauga, ON, Canada. L5S 1R5
    +1 (905) 564-5665
    info@septapharma.com

    Global Presence

    MENA
    Dubai/UAE: 210 Al Shaheen Building, Near NMC Hospital, Al Nahda 2, Dubai, UAE

    Asia
    Singapore: 135 Middle Road, Singapore, 188975
    India: 6 Bharucha Road, Mumbai, 40006

    North America
    Canada: 7035 Maxwell Road, Mississauga, Ontario
    USA: 444 Flower Street, Los Angeles, CA 90071

    Europe
    Switzerland: Talstrasse 20, Zurich, 8001, Switzerland.

    2024 © Septa | All rights reserved.